Valuation: Sunflower Pharmaceutical Group Co.,Ltd

Market Cap 6.71B 986M 865M 797M 746M 1.4B 93.05B 1.43B 9.58B 3.71B 45.99B 3.7B 3.62B 159B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 4.22B 620M 544M 501M 469M 880M 58.49B 898M 6.02B 2.33B 28.91B 2.33B 2.28B 100B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-2.96%
1 week-5.04%
Current month-12.16%
1 month-10.23%
3 months-7.26%
6 months-22.83%
Current year-22.21%
1 week 11.45
Extreme 11.45
12.56
1 month 11.45
Extreme 11.45
13.14
Current year 11.45
Extreme 11.45
15.19
1 year 11.45
Extreme 11.45
17.17
3 years 11.45
Extreme 11.45
30.79
5 years 11.45
Extreme 11.45
31.48
10 years 11.45
Extreme 11.45
31.48
Manager TitleAgeSince
Chief Executive Officer 44 07/01/2019
Director of Finance/CFO 49 06/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap.
17/07/24Buy 500 0.0001%
22/01/20Sell

Director

246,300 0.0462%
01/01/20Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%-5.04%-26.53%-50.86% 986M
-0.32%-2.95%-15.89%-9.30% 12.33B
-2.14%-4.72%-38.81%-59.87% 4.51B
-0.57%-4.82%-17.28%-10.97% 4.11B
-3.74%-2.40%+4.56%-42.35% 3.6B
-3.92%-6.18%+6.51%-20.53% 3.58B
-1.01%-1.97%-12.32%-11.10% 3.44B
-2.50%-6.03%-15.56%-6.03% 2.91B
-4.14%-5.96%-11.08%-28.36% 2.23B
0.00%-3.73%-14.63%+22.05% 1.6B
Average -2.13%-3.74%-14.10%-21.73% 3.93B
Weighted average by Cap. -1.69%-3.70%-14.36%-20.10%

Financials

2024 2025
Net sales 3.38B 496M 435M 401M 376M 704M 46.83B 719M 4.82B 1.87B 23.14B 1.86B 1.82B 80.26B 2.32B 341M 299M 275M 258M 483M 32.14B 494M 3.31B 1.28B 15.89B 1.28B 1.25B 55.09B
Net income 492M 72.33M 63.42M 58.46M 54.73M 103M 6.82B 105M 703M 272M 3.37B 272M 266M 11.69B -258M -37.9M -33.23M -30.63M -28.68M -53.78M -3.58B -54.89M -368M -142M -1.77B -142M -139M -6.13B
Net Debt -2.29B -337M -295M -272M -255M -478M -31.75B -487M -3.27B -1.27B -15.69B -1.26B -1.24B -54.41B -2.49B -366M -321M -296M -277M -520M -34.56B -531M -3.56B -1.38B -17.08B -1.38B -1.35B -59.23B
Logo Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
26/06/26 CN¥11.49 -2.96% 4,543,200
25/06/26 CN¥11.84 -2.31% 4,597,707
24/06/26 CN¥12.12 -1.86% 5,151,200
23/06/26 CN¥12.35 +3.09% 7,602,841

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock